PFM Health Sciences, LP - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$15,875,000
+44.5%
469,6640.0%0.50%
+48.7%
Q1 2021$10,985,000
-18.8%
469,6640.0%0.34%
-29.6%
Q4 2020$13,526,000
-48.4%
469,664
-63.7%
0.48%
-60.8%
Q3 2020$26,236,000
-17.0%
1,294,977
+23.2%
1.21%
-26.0%
Q2 2020$31,594,000
+218.2%
1,051,390
+232.8%
1.64%
+101.1%
Q1 2020$9,929,000315,8940.82%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q1 2020
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders